Adel. K. El‐naggar

Adel. K. El‐naggar's AcademicInfluence.com Rankings

Adel. K. El‐naggar

Biology

#4795

World Rank

#7106

Historical Rank

Computational Biology

#68

World Rank

#68

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Adel. K. El‐naggar Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Adel. K. El‐naggar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comprehensive genomic characterization of head and neck squamous cell carcinomas (2015) (2860)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma (2014) (2007)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 (2011) (1652)
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. (2011) (1090)
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. (2016) (1065)
Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome (2004) (1010)
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. (1997) (825)
WHO classification of head and neck tumours (2017) (714)
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy (2012) (703)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal (2018) (636)
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. (2014) (627)
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. (1999) (507)
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. (1997) (492)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers. (2013) (487)
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. (2013) (467)
Predicting cancer development in oral leukoplakia: ten years of translational research. (2000) (465)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs (2010) (454)
Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma (2014) (450)
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway (2003) (417)
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. (2014) (400)
Genetic Alterations and Their Relationship in the Phosphatidylinositol 3-Kinase/Akt Pathway in Thyroid Cancer (2007) (396)
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. (2007) (387)
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. (1998) (385)
Patterns of somatic structural variation in human cancer genomes (2020) (377)
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. (1996) (373)
Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. (1999) (373)
Mortality risk from squamous cell skin cancer. (2005) (369)
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. (2008) (364)
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer (2014) (358)
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice (2004) (327)
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome (2006) (301)
Characterization of HPV and host genome interactions in primary head and neck cancers (2014) (296)
Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? (1998) (290)
In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. (1995) (286)
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. (2001) (275)
Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. (1999) (274)
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. (2012) (271)
Lymph Node Metastases from Cutaneous Squamous Cell Carcinoma of the Head and Neck (2005) (267)
p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistency (2012) (262)
Understanding the Biological Basis of Autofluorescence Imaging for Oral Cancer Detection: High-Resolution Fluorescence Microscopy in Viable Tissue (2008) (248)
Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance (2010) (244)
BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells (2004) (240)
PRAD‐1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma (1994) (240)
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. (2010) (229)
Whole exome sequencing of adenoid cystic carcinoma. (2013) (226)
Parathyroid carcinoma: A 22‐year experience (2004) (223)
Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. (1998) (222)
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. (2003) (220)
Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions (2009) (217)
Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma (2006) (216)
Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center (2010) (208)
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. (2008) (207)
High metastatic potential in mice inheriting a targeted p53 missense mutation. (2000) (206)
Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. (1996) (201)
Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. (1995) (196)
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma (2016) (195)
Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. (2001) (193)
Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. (2002) (192)
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). (2011) (190)
Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. (2008) (187)
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway (2003) (184)
HER2 Expression in Salivary Gland Carcinomas (2004) (183)
Ki‐67 immunostaining in node‐negative stage I/II breast carcinoma. Significant correlation with prognosis (1991) (181)
Epithelial to mesenchymal transition in head and neck squamous carcinoma (2008) (181)
Objective Detection and Delineation of Oral Neoplasia Using Autofluorescence Imaging (2009) (180)
CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior (2007) (179)
Olfactory neuroblastoma: The 22‐year experience at one comprehensive cancer center (2005) (178)
Differential Expression of Hormonal and Growth Factor Receptors in Salivary Duct Carcinomas: Biologic Significance and Potential Role in Therapeutic Stratification of Patients (2007) (174)
Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. (1995) (173)
Prognostic factors in mucoepidermoid carcinoma of the salivary glands (2012) (170)
p53 mutations and expression in ovarian cancers: correlation with overall survival. (1999) (170)
TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma (2010) (170)
Postoperative radiotherapy for malignant tumors of the parotid gland. (1997) (170)
Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer (2004) (170)
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. (1998) (169)
Genetic variants in selected pre‐microRNA genes and the risk of squamous cell carcinoma of the head and neck (2010) (169)
Multispectral optical imaging device for in vivo detection of oral neoplasia. (2008) (168)
Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. (1992) (164)
Intraparenchymal Nevus Cell Aggregates in Lymph Nodes: A Possible Diagnostic Pitfall With Malignant Melanoma and Carcinoma (2003) (163)
Overexpression of Separase induces aneuploidy and mammary tumorigenesis (2008) (163)
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. (2003) (158)
Proliferative verrucous leukoplakia and its related lesions. (1999) (157)
p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. (1995) (157)
Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas (2007) (155)
Adult rhabdomyosarcoma (2002) (154)
Localized fibrous tumor of the serosal cavities. Immunohistochemical, electron-microscopic, and flow-cytometric DNA study. (1989) (153)
An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2 (2001) (153)
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival. (1995) (151)
A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck (2012) (151)
High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma (2000) (150)
Loss of p53 drives neuron reprogramming in head and neck cancer (2020) (150)
Diagnostic Surgical Pathology of the Head and Neck. (2001) (149)
Muscularis Mucosa of Urinary Bladder Importance for Staging and Treatment (1987) (146)
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. (2003) (146)
Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations (2015) (144)
miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue (2009) (144)
Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer (2007) (143)
Sinonasal malignancies with neuroendocrine differentiation (2004) (143)
Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. (2002) (141)
Fine-Needle Aspiration of Salivary Glands: Its Utility and Tissue Effects (1992) (141)
Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification (1998) (140)
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. (1996) (138)
Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. (2000) (137)
p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. (2003) (135)
Outcomes in Patients with Adenoid Cystic Carcinoma of the Lacrimal Gland (2004) (134)
Intra-abdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. (1993) (133)
Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. (2015) (133)
Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous Carcinoma (2004) (133)
Pathology Consultation Thyroid Gland Ectopias (1996) (132)
Histogenesis of salivary gland neoplasms: a postulate with prognostic implications (1989) (131)
Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice (2007) (130)
Histopathologic Grading of Salivary Gland Neoplasms: III. Adenoid Cystic Carcinomas (1990) (129)
Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. (1999) (129)
Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB–NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome (2011) (128)
Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence (2004) (128)
The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. (2017) (125)
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. (1998) (125)
Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation. (2011) (124)
Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. (1997) (123)
c-erbB-2 amplification in node-negative human breast cancer. (1989) (123)
Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers (2014) (123)
Sinonasal adenoid cystic carcinoma (2007) (123)
Gene Expression Profiling Predicts the Development of Oral Cancer (2011) (123)
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors (2016) (122)
Biology and management of salivary gland cancers. (2012) (122)
Loss of PTEN expression as a prognostic marker for tongue cancer. (2001) (121)
High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid Carcinoma (2009) (120)
In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. (2008) (118)
Akt activation correlates with adverse outcome in tongue cancer (2005) (118)
Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance (2010) (118)
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. (2021) (118)
Prognosis and risk factors for early‐stage adenoid cystic carcinoma of the major salivary glands (2012) (117)
The influence of resection and aneuploidy on mortality in oral leukoplakia. (2004) (117)
Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. (1996) (116)
Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer (2010) (116)
Rhabdomyosarcoma of the Nose and Paranasal Sinuses in Adults and Children (1995) (115)
p21 delays tumor onset by preservation of chromosomal stability (2006) (114)
Multiple stress signals activate mutant p53 in vivo. (2011) (113)
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. (2016) (110)
Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. (2002) (108)
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. (1996) (107)
“Inflammatory Pseudotumor”: What is it? How Does it Behave? (1995) (106)
Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. (1995) (106)
A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry (2012) (106)
Thyroid gland ectopias. (1996) (104)
Expression of galectins in head and neck squamous cell carcinoma (1996) (104)
Parathyroid carcinoma: Evaluation and interdisciplinary management (2004) (104)
The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase. (2005) (102)
Noninvasive evaluation of oral lesions using depth‐sensitive optical spectroscopy (2009) (102)
Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma (2011) (102)
CpG island methylation profiling in human salivary gland adenoid cystic carcinoma (2011) (101)
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells (2005) (101)
Salivary Gland Tumors in Children (1991) (99)
Renal cell carcinoma. A clinicopathologic and dna flow cytometric analysis of 103 cases (1989) (99)
Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. (1994) (98)
Radiotherapy in the management of giant cell tumor of bone. (2003) (98)
Histopathologic Grading of Salivary Gland Neoplasms: II. Acinic Cell Carcinomas (1990) (98)
Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. (2003) (98)
Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. (2002) (97)
Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. (1995) (97)
Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: A clinicopathologic and flow cytometric investigation (1995) (97)
A genetic mouse model for metastatic lung cancer with gender differences in survival (2007) (97)
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. (2004) (96)
Gene Expression Profiling of Differentiated Thyroid Neoplasms (2004) (96)
Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. (2001) (96)
HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. (1995) (96)
Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. (1998) (95)
Sarcomatoid Carcinoma of the Head and Neck: Molecular Evidence for Evolution and Progression From Conventional Squamous Cell Carcinomas (2003) (95)
Squamous cell carcinoma of the maxillary sinus. (1993) (95)
Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions (2008) (94)
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. (2001) (94)
Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. (1997) (94)
Papillary squamous cell carcinomas of the upper aerodigestive tract: A clinicopathologic and molecular study (2000) (93)
Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene. (1995) (93)
Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities (2008) (92)
Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer (2005) (92)
Long‐term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3‐decade survey (2015) (91)
Pleomorphic adenoma [1] (1998) (91)
Limitations of size as a criterion in the evaluation of adrenal tumors. (2000) (91)
Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases. (1991) (91)
Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. (1996) (91)
Urban legends series: oral leukoplakia. (2013) (90)
Signet‐Ring-Cell Carcinoma of the Prostate: Electron‐Microscopic and Immunohistochemical Studies of Eight Cases (1988) (90)
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. (2006) (90)
Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy‐glucose (2009) (90)
Allergic fungal sinusitis: a clinicopathologic study of 16 cases. (1996) (89)
Ewing's Sarcoma and Peripheral Primitive Neuroectodermal Tumor: An Interim Report (1996) (88)
Surgical Management and Prognostic Factors in Patients with Subungual Melanoma (1994) (88)
Confocal microscopy for real-time detection of oral cavity neoplasia. (2003) (88)
Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. (2016) (88)
Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. (2005) (87)
Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. (2016) (87)
Optimization of long‐term outcomes for patients with esthesioneuroblastoma (2014) (86)
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma (2009) (85)
The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl‐2 in laryngeal squamous cell carcinoma (1998) (85)
The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasiveness of Human Cancer Cells (2004) (84)
Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma (1997) (84)
Sequential p53 mutation analysis of pre‐invasive and invasive head and neck squamous carcinoma (1995) (84)
Oncocytic adrenal cortical carcinoma. (1991) (84)
Synovial sarcoma a DNA flow cytometric study (1990) (83)
Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. (1993) (83)
A miRNA signature associated with human metastatic medullary thyroid carcinoma. (2013) (83)
High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas. (2007) (82)
Proton Therapy Reduces Treatment-Related Toxicities for Patients with Nasopharyngeal Cancer: A Case-Match Control Study of Intensity-Modulated Proton Therapy and Intensity-Modulated Photon Therapy (2015) (82)
Human papillomavirus and WHO type I nasopharyngeal carcinoma (2010) (82)
A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo. (1994) (82)
Phase II study of gefitinib in patients with advanced salivary gland cancers (2015) (81)
Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma (1998) (80)
Biological significance of c-met over expression in papillary renal cell carcinoma. (2002) (80)
Genetic polymorphisms in DNA base‐excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck (2007) (79)
Management of nonsinonasal neuroendocrine carcinomas of the head and neck (2003) (79)
Unfavorable prognosis of CRTC1‐MAML2 positive mucoepidermoid tumors with CDKN2A deletions (2010) (78)
Polymorphisms of FAS and FAS Ligand Genes Involved in the Death Pathway and Risk and Progression of Squamous Cell Carcinoma of the Head and Neck (2006) (78)
Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer. (2015) (77)
Teratomas of the Head and Neck with Emphasis on Malignancy (1995) (76)
Farnesyl transferase inhibitors impair chromosomal maintenance in cell lines and human tumors by compromising CENP-E and CENP-F function (2007) (75)
Detection and diagnosis of oral neoplasia with an optical coherence microscope. (2004) (74)
Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. (2010) (73)
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer. (2017) (73)
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma (2009) (73)
Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. (2003) (73)
Nonnasopharyngeal lymphoepithelioma of the head and neck (1998) (73)
A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality. (1996) (73)
Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. (2006) (73)
Primary carcinoid tumor of testis. Immunohistochemical, ultrastructural, and DNA flow cytometric study of three cases with a review of the literature (1993) (72)
Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma (2010) (72)
Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. (1999) (72)
Molecular genetic alterations in carcinoma ex‐pleomorphic adenoma: A putative progression model? (2000) (72)
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. (2015) (72)
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53 (2014) (71)
Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. (2001) (70)
TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior (2013) (70)
Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. (1994) (70)
Deletion of 1p32-p36 Is the Most Frequent Genetic Change and Poor Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands (2008) (70)
Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. (2007) (70)
Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma (2007) (70)
A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. (2009) (69)
Transitional cell carcinoma in high‐grade high‐stage ovarian carcinoma. An indicator of favorable response to chemotherapy (1989) (69)
Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas (1995) (69)
Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes (2016) (68)
Neuroendocrine Tumors of Larynx (1992) (67)
Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. (2005) (67)
Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. (2010) (67)
Epithelial-Myoepithelial Carcinoma of Salivary Glands (1992) (67)
DNA Ploidy in Testicular Germ Cell Neoplasms Histogenetic and Clinical Implications (1992) (67)
Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance (2005) (66)
Calcium Oxalate Crystals in Breast Biopsies The Missing Microcalcifications (1990) (66)
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model (2006) (66)
Flow cytometric analysis of the DNA content of non‐small cell lung cancer ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung (1990) (66)
Radiation therapy for early-stage carcinoma of the oropharynx. (2004) (65)
Altered expression of bcl‐2 family member proteins in nonmelanoma skin cancer (1999) (65)
Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. (1996) (64)
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53) (2000) (64)
Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma (2011) (63)
Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck (2007) (62)
Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. (1993) (62)
Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma (2005) (62)
Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. (2012) (62)
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. (2000) (61)
Loss of Fhit expression is a predictor of poor outcome in tongue cancer. (2001) (61)
The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. (2006) (60)
Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: A case‐control analysis (2005) (58)
Radiation Therapy for Early Stage (T1‐T2) Sarcomatoid Carcinoma of True Vocal Cords: Outcomes and Patterns of Failure (1998) (58)
Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER‐2/neu gene amplification in breast cancer fine‐needle samples (1999) (58)
Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications (2014) (58)
IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer (2010) (57)
c-erbB-2/neu Oncogene and Ki-67 Analysis in the Assessment of Palatal Salivary Gland Neoplasms (1995) (57)
Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer (2016) (57)
ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia (2009) (57)
STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma (2011) (56)
Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. (1998) (56)
Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. (2005) (56)
Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification (2002) (56)
Primary sarcomas of the kidney. A clinicopathologic and dna flow cytometric study of 17 cases (1990) (55)
Survival Impact of Planned Restaging and Early Surgical Salvage Following Definitive Chemoradiation for Locally Advanced Squamous Cell Carcinomas of the Oropharynx and Hypopharynx (2005) (55)
A Far-red Fluorescent Contrast Agent to Image Epidermal Growth Factor Receptor Expression (2004) (55)
Epithelioid Hemangioendothelioma of the Head and Neck: Role of Podoplanin in the Differential Diagnosis (2008) (54)
Sebaceous Lesions of Salivary Glands and Oral Cavity (1990) (54)
Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma (2006) (54)
Molecular Analysis of Chromosome 16q Regions in Dermal Analogue Tumors of Salivary Glands: A Genetic Link to Dermal Cylindroma? (2002) (54)
Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural, and DNA flow cytometric studies. (1991) (54)
Role of Cyclooxygenase-2 in Tumor Progression and Survival of Head and Neck Squamous Cell Carcinoma (2009) (54)
Carcinoid tumor of the larynx. A critical review of the literature. (1991) (53)
Gain‐of‐function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K‐ras (2011) (53)
New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development (2015) (53)
Fine‐needle sampling findings in 26 carcinoma ex pleomorphic adenomas: Diagnostic pitfalls and clinical considerations (1999) (53)
Reduced DNA Repair Capacity for Removing Tobacco Carcinogen–Induced DNA Adducts Contributes to Risk of Head and Neck Cancer but not Tumor Characteristics (2010) (53)
Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation (2003) (52)
Dual inhibition of epidermal growth factor receptor and insulin‐like growth factor receptor I: Reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma (2011) (52)
Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. (2008) (52)
Genetic alterations in oral squamous cell carcinoma of young adults. (1999) (52)
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial (2017) (52)
The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. (1999) (52)
DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma (1989) (52)
Cell type‐dependent biomarker expression in adenoid cystic carcinoma (2010) (51)
Typical and atypical bronchopulmonary carcinoids. A clinicopathologic and flow cytometric study. (1991) (51)
Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia (2006) (51)
Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. (2008) (51)
Mucoepidermoid carcinoma involving Warthin tumor. A report of five cases and review of the literature. (2000) (51)
Regulation of urokinase‐type plasminogen activator expression in squamous‐cell carcinoma of the oral cavity (1993) (51)
Molecular Heterogeneity in Mucoepidermoid Carcinoma: Conceptual and Practical Implications (2013) (51)
Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. (2003) (50)
Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. (2007) (50)
Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines (1999) (50)
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck (2001) (50)
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. (2011) (50)
Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. (2001) (49)
Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: applications for diagnosis of oral precancer. (2008) (49)
Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations. (1991) (49)
Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. (2003) (49)
Cytogenetic analysis of a primary salivary gland myoepithelioma. (1999) (49)
Myofibroblastoma of the tongue. An immunohistochemical, ultrastructural, and flow cytometric study. (1990) (48)
Repair Capacity for UV Light–Induced DNA Damage Associated with Risk of Nonmelanoma Skin Cancer and Tumor Progression (2007) (48)
Association between the V109G Polymorphism of the p27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma (2004) (48)
Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. (2006) (47)
Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody (2011) (47)
Head & neck optical diagnostics: vision of the future of surgery (2009) (47)
A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. (2004) (47)
Polymerase chain reaction–based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma (1993) (47)
Carcinomas metastatic to follicular adenomas of the thyroid gland. Report of two cases. (1994) (47)
Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome (2011) (46)
Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. (2003) (46)
Aggressive stage I grade 1 endometrial carcinoma (1992) (46)
Basaloid Monomorphic Adenomas (1991) (46)
A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. (2004) (46)
Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. (1991) (46)
Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell. (1996) (45)
Primary renal carcinoid tumor with molecular abnormality characteristic of conventional renal cell neoplasms. (1995) (45)
Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance. (2004) (45)
DNA content and proliferative activity of myoepitheliomas (1989) (45)
Pleomorphic adenoma (benign mixed tumor) of the breast. An immunohistochemical, flow cytometric, and ultrastructural study and review of the literature. (1990) (45)
Warthin's Tumor (1990) (45)
Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A. (2004) (45)
Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma (1999) (44)
Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer (2010) (44)
Cytomorphologic, immunocytochemical, and nucleic acid flow cytometric study of 50 lymph nodes by fine‐needle aspiration. Comparison with results obtained by subsequent excisional biopsy (1991) (44)
PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions (2017) (44)
GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland. (2019) (44)
Anaplastic ameloblastic fibrosarcoma arising from recurrent ameloblastic fibroma: restricted molecular abnormalities of certain genes to the malignant transformation. (2007) (44)
Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck (2008) (44)
High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. (2002) (43)
“Adenocarcinoma, not otherwise Specified”: A Diminishing Group of Salivary Carcinomas (1992) (43)
Chromosome polysomy and histological characteristics in oral premalignant lesions. (2001) (43)
Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. (1997) (43)
Cyclin D1 and Cancer Development in Laryngeal Premalignancy Patients (2009) (43)
Moderately Differentiated Neuroendocrine Carcinoma (Atypical Carcinoid) of the Larynx: A Clinically Aggressive Tumor (2005) (43)
Carcinoma ex-pleomorphic adenoma of the nasal cavity: a report of two cases (1995) (43)
Benign metastatic mixed tumours or unrecognized salivary carcinomas? (1988) (43)
MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome (2013) (43)
A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets (2014) (42)
Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation (1995) (42)
Compliance with quality assurance measures in patients treated for early oral tongue cancer (2010) (42)
Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification. (2008) (42)
Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells. (1996) (42)
Quantitative Promoter Hypermethylation Analysis of Cancer-Related Genes in Salivary Gland Carcinomas: Comparison with Methylation-Specific PCR Technique and Clinical Significance (2008) (42)
Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma (2006) (42)
Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. (2004) (42)
Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. (2013) (41)
High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. (2008) (41)
Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. (2002) (41)
Sex differences in oncogenic mutational processes (2019) (41)
Genetic alterations in acinic cell carcinoma of the parotid gland determined by microsatellite analysis. (1998) (41)
Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. (2009) (41)
Identifying the estrogen receptor coactivator PELP1 in autophagosomes. (2007) (40)
Papillary Neoplasms (Heffner's Tumors) of the Endolymphatic SAC (1993) (40)
Mammary tumor modifiers in BALB/cJ mice heterozygous for p53 (2007) (40)
DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer (2009) (40)
The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis. (2006) (40)
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. (2009) (40)
Tumor specific gene expression profiles in human leiomyosarcoma (2002) (40)
p53: Fifteen Years After Discovery (1995) (40)
DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance. (1990) (40)
Sinonasal hemangiopericytomas. A clinicopathologic and DNA content study. (1992) (40)
Dual Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Inhibition with NVP-AEE788 for the Treatment of Aggressive Follicular Thyroid Cancer (2006) (40)
Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. (2007) (40)
Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma. (2010) (40)
UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53 (2001) (40)
Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data. (1993) (39)
Pathology Consultation Nonsquamous Carcinomas of the Larynx (1992) (39)
Developmental transcription factor EN1—a novel biomarker in human salivary gland adenoid cystic carcinoma * (2012) (39)
Pathology Consultation Solitary Fibrous Tumor (1993) (39)
Intratumoral DNA content heterogeneity in laryngeal squamous cell carcinoma. (1992) (39)
A clinicopathologic study of three carcinoid tumors metastatic to the orbit. Immunohistochemical, ultrastructural, and DNA flow cytometric studies. (1990) (39)
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen (2012) (39)
Family history of cancer and risk of sporadic differentiated thyroid carcinoma (2012) (39)
Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults (2012) (38)
Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. (1994) (38)
DNA flow cytometry of acinic cell carcinomas of major salivary glands (1990) (38)
An exploratory study of the informational and psychosocial needs of patients with human papillomavirus-associated oropharyngeal cancer. (2013) (38)
Pseudosarcomatous Proliferative Lesions of Soft Tissues (1994) (37)
CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: Evidence for a common genetic association (2008) (37)
Giant cell tumor of bone: A clinicopathologic and DNA flow cytometric analysis (1990) (37)
Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the m.d. Anderson cancer center. (1996) (37)
Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. (1997) (36)
Implications of Methylation Patterns of Cancer Genes in Salivary Gland Tumors (2006) (36)
Exophytic signet-ring cell carcinoma of the colorectum. (1991) (36)
Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. (2004) (36)
No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. (2004) (36)
Lower gingival carcinoma. Clinical and pathologic determinants of regional metastases. (1996) (36)
Comparative cytologic and histologic study of fifteen salivary basal‐cell tumors: Differential diagnostic considerations (1999) (35)
Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study. (1991) (35)
Primacy of surgery in the management of mucoepidermoid carcinoma in children (2011) (34)
The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. (2016) (34)
Fine needle aspiration of lymphoblastic lymphoma. A multiparameter diagnostic approach. (1992) (34)
Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiation. (2006) (34)
Molecular and Clinicopathologic Comparisons of Head and Neck Squamous Carcinoma Variants: Common and Distinctive Features of Biological Significance (2004) (34)
Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer (2010) (34)
Flow cytometric DNA content of adenoid cystic carcinoma of submandibular gland. Correlation of histologic features and prognosis. (1990) (34)
Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma. (2009) (33)
The Six-Nucleotide Deletion/Insertion Variant in the CASP8 Promoter Region Is Inversely Associated with Risk of Squamous Cell Carcinoma of the Head and Neck (2010) (33)
Plasma cell dyscrasias and the head and neck. (2002) (33)
Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. (2007) (33)
Craniofacial Resection for Nonmelanoma Skin Cancer of the Head and Neck (2005) (33)
Primary colonic-type adenocarcinoma of the base of the tongue: a previously unreported phenotype. (2009) (33)
Fine-needle aspiration cytology and flow cytometry of intracystic papillary carcinoma of breast. (1990) (33)
Proliferative Verrucous Leukoplakia (PVL): A Review of an Elusive Pathologic Entity! (2013) (33)
Prognostic factors in mucoepidermoid carcinomas of major salivary glands: a clinicopathologic and flow cytometric study. (1994) (32)
Minor salivary gland tumors of the lip and buccal mucosa (1989) (32)
Polymorphic TP53BP1 and TP53 Gene Interactions Associated with Risk of Squamous Cell Carcinoma of the Head and Neck (2007) (32)
Induction chemotherapy (CT) with weekly paclitaxel, carboplatin, and cetuximab for squamous cell carcinoma of the head and neck (HN). (2006) (32)
Proliferative verrucous leukoplakia: Recognition and differentiation from conventional leukoplakia and mimics (2014) (32)
Primary synovial sarcoma of the parotid gland. (2004) (32)
ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion! (2005) (32)
Prognostic factors in adenocarcinoma of the salivary glands. (2015) (32)
Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma (2014) (32)
Epidermal growth factor expression in human colon and colon carcinomas: Anti‐sense epidermal growth factor receptor rna down‐regulates the proliferation of human colon cancer cells (1995) (31)
Functional Variants of the NEIL1 and NEIL2 Genes and Risk and Progression of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx (2008) (31)
The role of trastuzumab in the management of salivary ductal carcinomas. (2013) (31)
Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center (2017) (31)
The future of medical diagnostics: review paper (2011) (31)
In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. (2007) (31)
Myoepithelium in salivary and mammary neoplasms is host-friendly. (1999) (31)
CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study. (2015) (31)
Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland (2020) (30)
Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia. (2009) (30)
Papillary renal cell carcinoma: clinical implication of DNA content analysis. (1993) (30)
KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma (2011) (30)
Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance. (1996) (30)
Carcinomas arising in multilocular thymic cysts of the neck: a clinicopathological study of three cases (2004) (30)
Terminal Duct Adenocarcinomas of Salivary Tissues (1991) (30)
CRTC1/MAML2 fusion transcript in central mucoepidermoid carcinoma of mandible--diagnostic and histogenetic implications. (2010) (30)
Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer. (1994) (30)
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases (2018) (30)
Don't Confuse Dental Soft Tissues with Odontogenic Tumors (1996) (29)
Loss of E‐cadherin and p27 expression is associated with head and neck squamous tumorigenesis (2005) (29)
Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity (2000) (29)
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets (2020) (29)
Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications (1991) (29)
Correlation of p 53 Mutations with Resistance to Platinum-based Chemotherapy and Shortened Survival in Ovarian Cancer 1 (2001) (29)
Emerging Roles for Multimodal Optical Imaging in Early Cancer Detection: A Global Challenge (2010) (28)
Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. (2014) (28)
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck (2021) (28)
Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported. (2015) (28)
Imaging Findings of Head and Neck Dermatofibrosarcoma Protuberans (2014) (28)
Long‐term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches (2016) (28)
Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. (1992) (28)
Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. (1994) (28)
Interphase cytogenetics in mammographically detected breast lesions. (1996) (28)
The Cancer Genome Atlas: Integrated analysis of genome alterations in squamous cell carcinoma of the head and neck. (2013) (28)
Cystic Fibrosis and the Sinonasal Tract (1996) (28)
Mucosal Melanomas of the Head and Neck (1998) (28)
Tumors of the middle ear and endolymphatic sac. (1994) (28)
Medullary (thyroid) carcinoma-like carcinoids of the larynx (1991) (28)
Prognostic value of p16 expression in Epstein‐Barr virus–positive nasopharyngeal carcinomas (2016) (28)
Clear Cell Hidradenoma of the Skin—A Third Tumor Type With a t(11;19)-Associated TORC1-MAML2 Gene Fusion: Genes Chromosomes Cancer. 2005;43:202–205 (2006) (28)
Flow cytometric (DNA content and S‐phase fraction) analysis of breast cancer (1993) (28)
Primary osteosarcoma of the lung. Report of two cases and review of the literature. (1990) (28)
Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis. (1995) (28)
Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features. (1996) (28)
Noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP) in thyroid tumor classification (2018) (27)
Therapeutic Efficacy of p53 Restoration in Mdm2-Overexpressing Tumors (2014) (27)
High Correlation with Survival of Proliferating Cell Nuclear Antigen Expression in Mucoepidermoid Carcinoma of the Parotid Gland (1994) (27)
Malignant Melanoma Arising within a Burn Scar Case Report and Review of the Literature (2001) (27)
Hyalinizing Clear Cell Carcinoma of Salivary Origin (1994) (27)
Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasia. (2010) (27)
Flow cytometric analysis of apoptosis and bcl-2 in primary breast carcinomas: clinical and biological implications. (1996) (27)
Molecular profiling of sinonasal undifferentiated carcinoma (2014) (27)
Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. (2005) (26)
Near‐diploidy: A new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy (1994) (26)
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. (2019) (26)
Neurothekeoma of the oral cavity: case report and review of the literature. (1992) (26)
Terminal duct adenocarcinomas of the parotid gland (1995) (26)
Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma. (2011) (26)
World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications (2018) (26)
Ultrastructure of adrenal cortical carcinoma. (1994) (26)
Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions. (2002) (26)
Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes (2017) (26)
Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. (1998) (26)
Single-nucleotide polymorphisms at the TP 53-binding or responsive promoter regions of BAX and BCL 2 genes and risk of squamous cell carcinoma of the head and neck (2007) (26)
Pathology Consultation Epithelial Choristomas and Teratomas of the Tongue (1993) (26)
Metastatic lobular breast carcinoma simulating primary colon cancer. (1992) (26)
Tubular seminoma. An immunohistochemical and DNA flow-cytometric study of four cases. (1994) (26)
Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma. (2000) (25)
Renal oncocytoma and granular renal cell carcinoma. A comparative clinicopathologic and DNA flow cytometric study. (1992) (25)
Conditional Survival Analysis of Patients With Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram (2017) (25)
Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain‐of‐function mutant p53R172H (2016) (25)
Seminal Vesicle Involvement by In Situ and Invasive Transitional Cell Carcinoma of the Bladder (1987) (25)
Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. (2013) (25)
Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis. (1999) (25)
Sebaceous carcinoma ex-pleomorphic adenoma: a rare phenotypic occurrence. (2004) (24)
Hürthle cell tumors of the thyroid. A flow cytometric DNA analysis. (1988) (24)
A single nucleotide polymorphism in the alcohol dehydrogenase 7 gene (alanine to glycine substitution at amino acid 92) is associated with the risk of squamous cell carcinoma of the head and neck (2010) (24)
Loss of Fhit Expression in Head and Neck Squamous Cell Carcinoma and Its Potential Clinical Implication (2004) (24)
Phase II study of neoadjuvant cemiplimab prior to surgery in patients with stage III/IV (M0) cutaneous squamous cell carcinoma of the head and neck (CSCC-HN) (2019) (24)
Angiomyolipoma of kidney with lymph node involvement. DNA flow cytometric analysis. (1990) (24)
Cytologic features of intraabdominal desmoplastic small round cell tumor. A case report. (1995) (24)
Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival (2006) (24)
Interphase cytogenetics in paraffin-embedded sections from renal cortical neoplasms. Correlation with cytogenetic and flow cytometric DNA ploidy analyses. (1994) (24)
Management of the lymph node‐positive neck in the patient with human papillomavirus‐associated oropharyngeal cancer (2014) (24)
Salivary gland tumours. (2000) (23)
Clear cell carcinoid tumour of the stomach (1993) (23)
Real‐time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular‐specific contrast agent (2006) (23)
Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. (1995) (23)
Vandetanib Inhibits Growth of Adenoid Cystic Carcinoma in an Orthotopic Nude Mouse Model (2008) (23)
Development and characterization of salivary adenoid cystic carcinoma cell line. (2014) (23)
Merkel cell carcinoma metastatic to the testis. (1990) (23)
p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas. (2001) (23)
Minor salivary gland malignancies in the pediatric population (2012) (23)
Biological Role of Estrogen Receptor β in Salivary Gland Adenocarcinoma Cells (2006) (22)
Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma (2017) (22)
Inflammatory pseudotumor of the urinary bladder. (1993) (22)
Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. (1999) (22)
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
Microsatellite Alterations at Chromosome 8q Loci in Pleomorphic Adenoma (1997) (22)
Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature (2017) (22)
Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression (2018) (22)
Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. (2013) (22)
The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy. (1994) (22)
Verrucous carcinoma (carcinoma cuniculatum) of the head and neck: what do we know now that we did not know a decade ago? (2011) (22)
c-kit gene mutations in adenoid cystic carcinoma are rare (2010) (22)
Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution. (2005) (22)
Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. (2011) (22)
Loss of Epithelial p53 and αv Integrin Cooperate through Akt to Induce Squamous Cell Carcinoma yet Prevent Remodeling of the Tumor Microenvironment (2014) (22)
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local‐regional recurrence of melanoma (1994) (21)
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy (2018) (21)
In vitro benzo[a]pyrene diol epoxide‐induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck (2007) (21)
PCR‐Based RFLP Screening of the Commonly Deleted 3p Loci in Renal Cortical Neoplasms (1993) (21)
Salivary neoplasms of the palate: a flow cytometric and clinicopathological analysis (1993) (21)
Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials. (1997) (21)
Mitochondrial Mutations in Adenoid Cystic Carcinoma of the Salivary Glands (2009) (21)
Malignant lymphoma of the thyroid: A report of two cases diagnosed by fine‐needle aspiration (1991) (21)
Development and characterization of six new human papillary thyroid carcinoma cell lines. (2015) (21)
Angiomatoid malignant fibrous histiocytoma: Flow cytometric DNA analysis of six cases (1989) (20)
Flow cytometric analysis of apoptosis and bcl-2 in human solid neoplasms. (1995) (20)
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer (2018) (20)
Extramedullary plasmacytoma mimicking primary colonic carcinoma in a patient with Crohn's disease. Case report and literature review. (1996) (20)
Primary sarcomas of the salivary glands: Case series and literature review (2013) (20)
Four patients with cutaneous metastases from medullary thyroid cancer. (2008) (20)
Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum. (1990) (19)
Confocal Microscopy and Molecular-Specific Optical Contrast Agents for the Detection of Oral Neoplasia (2007) (19)
Delivery of cytoplasmic proteins to autophagosomes (2008) (19)
Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. (1996) (19)
Granular cell tumor of the biliary tree. (1992) (19)
Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Three Cases of Fibroblastic Osteosarcoma (2005) (19)
Cisplatin and gemcitabine combined with herceptin in patients (pt) with her2 overexpressing, untreated, advanced, non-small-cell lung cancer (NSCLC): a phase II trial (2001) (19)
DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors. (1995) (18)
Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin. (2000) (18)
Gastrointestinal stromal tumors: DNA flow-cytometric study of 58 patients with at least five years of follow-up. (1989) (18)
Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells. (2006) (18)
Radiologic-pathologic conferences of the University of Texas M. D. Anderson Cancer Center: Extraskeletal osteosarcoma of the pleura. (2003) (18)
What Is New in the World Health Organization 2017 Histopathology Classification? (2017) (17)
Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings. (2011) (17)
Abstract 1117: Comprehensive genomic characterization of squamous cell carcinoma of the head and neck in the Cancer Genome Atlas. (2013) (17)
Quiz Case 1 (2000) (17)
Early postoperative epidermal growth factor receptor inhibition: Safety and effectiveness in inhibiting microscopic residual of oral squamous cell carcinoma in vivo (2013) (17)
Intratumoral Genetic Heterogeneity in Primary Head and Neck Squamous Carcinoma Using Microsatellite Markers (1997) (17)
Myofibroblastoma of the larynx: A study of two cases (2003) (17)
Stromal neoplasms of the breast: A comparative flow cytometric study (1990) (17)
Genotypic analysis of primary head and neck squamous carcinoma by combined fluorescence in situ hybridization and DNA flow cytometry. (1996) (17)
Malignant Melanoma Metastatic to Gastrointestinal Tract (1994) (16)
Numerical chromosomal changes in DNA hypodiploid solid tumors: restricted loss and gain of certain chromosomes. (1999) (16)
Proliferative Activity in Primary Breast Carcinomas is a Salient Prognostic Factor (2005) (16)
The prognostic significance of flow cytometric DNA analysis (1992) (16)
Epithelioid sarcoma. Flow cytometric study of dna content and regional dna heterogeneity (1992) (16)
Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration. (2015) (16)
Brain derived neutrophic factor (BDNF) coordinates lympho-vascular metastasis through a fibroblast-governed paracrine axis in the tumor microenvironment (2017) (16)
Comparative image and flow cytometric TUNEL analysis of fine needle samples of breast carcinoma. (2001) (16)
Synovial Sarcoma of the Tongue: Case Report and Review of the Literature (1992) (16)
Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms. (1992) (15)
Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation. (2008) (15)
Nucleolar organizer regions (NORs) and myoepitheliomas: a comparison with DNA content and clinical course (1992) (15)
Ewing's Sarcoma and Primitive Neuroectodermal Tumors: Cytogenetic Cynosures Seeking a Common Histogenesis (1997) (15)
Rhabdomyosarcoma of the adult head and neck: a clinicopathological and DNA ploidy study (1993) (15)
Uterine stromal neoplasms: a clinicopathologic and DNA flow cytometric correlation. (1991) (15)
Flow Cytometry in Clinical Diagnosis, 3rd ed. (2002) (15)
Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. (1994) (15)
S‐phase fraction as an independent prognostic factor of long‐term overall survival in patients with early‐stage or locally advanced invasive breast carcinoma (2005) (15)
Intratumoral DNA content variability. A study of non-small cell lung cancer. (1991) (14)
Reply to B. O'Sullivan et Al. (2015) (14)
Residual nodal disease in patients with advanced‐stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival (2012) (14)
Retracted: Genome‐wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes (2015) (13)
Genotypic characterization of a primary mucoepidermoid carcinoma of the parotid gland by cytogenetic, fluorescence in situ hybridization, and DNA ploidy analysis. (1996) (13)
Pathology Consultation Intracellular Crystalline Deposits in Lymphoplasmacellular Disorders (1997) (13)
An Orthotopic Murine Model of Sinonasal Malignancy (2008) (13)
Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions. (1994) (13)
Methods in molecular surgical pathology. (2002) (13)
Parotid gland plasmacytoma with crystalline deposits. (1991) (13)
Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands (2015) (13)
Expression of retinoid receptors in sebaceous cell carcinoma (2005) (13)
Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. (2017) (12)
Chromosomal and DNA ploidy characterization of salivary gland neoplasms by combined FISH and flow cytometry. (1997) (12)
CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. (2000) (12)
Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study. (1991) (12)
Cyclin D 1 and p 16 Alterations in Advanced Premalignant Lesions of the Upper Aerodigestive Tract : Role in Response to Chemoprevention and Cancer Development 1 (2001) (12)
Limited nonrandom chromosomal aberrations in a recurrent adenoid cystic carcinoma of the parotid gland. (1999) (12)
Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes (2018) (12)
Interphase cytogenetics of renal cortical neoplasms. Correlation with DNA ploidy by flow cytometry. (1995) (12)
Fine‐needle aspiration evaluation of lymphoproliferative lesions in human immunodeficiency virus‐positive patients. A multiparameter approach (1991) (12)
Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus–associated oropharyngeal cancer (2016) (12)
Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content. (1990) (12)
Well-differentiated serous ovarian carcinoma presenting as a breast mass: a case report and flow cytometric DNA study. (1991) (12)
Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neck. (1993) (12)
Solid and papillary tumor of the pancreas: ultrastructural observations on two contrasting cases. (1997) (12)
Metastatic acinic cell carcinoma in a neurofibroma mistaken for carcinosarcoma (2005) (12)
Single- and double-stranded RNA measurements by flow cytometry in solid neoplasms. (1991) (11)
Association between DNA content and tumor suppressor gene expression and aggressiveness of atypical teratoid/rhabdoid tumors (2002) (11)
Pathobiology of head and neck squamous tumorigenesis. (2007) (11)
Solid tumor DNA content analysis. (2004) (11)
At the frontiers of surgery: review (2011) (11)
Head & Neck Oncology: purpose, scope and goals-charting the future (2009) (11)
Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland (2015) (11)
Trisomy 5 as the sole chromosomal abnormality in a primary mucoepidermoid carcinoma of the minor salivary gland. (1994) (11)
Molecular profile of advanced-stage transitional cell carcinoma of the ovary. (1997) (11)
Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance. (1994) (11)
Primary intestinal‐like adenocarcinoma of major salivary glands: 2 instances of previously undocumented phenotype (2013) (11)
Two AgNOR counts in fine‐needle aspirates of lymphoproliferative disorders compared with acridine orange flow cytometry (1992) (11)
Intraluminal crystalloids in struma ovarii. Immunohistochemical, DNA flow cytometric, and ultrastructural study. (1991) (11)
Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma (2020) (11)
Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. (1997) (11)
Renal cell carcinoma with osteoclast-like giant cells (1993) (11)
Human Papillomavirus & WHO Type I Nasopharyngeal Carcinoma (2010) (10)
Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma. (1990) (10)
The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD 1839 ( Iressa ) Suppresses cSrc and Pak 1 Pathways and Invasiveness of Human Cancer Cells (2004) (10)
Concurrent flow cytometric analysis of DNA and RNA. (2004) (10)
Fine‐needle sampling of primary neuroendocrine carcinomas of salivary glands: Cytohistological correlations and clinical analysis (2001) (10)
Malignant rhabdoid tumor arising from a pleomorphic adenoma. (2004) (10)
Editor's perspective on the 4th edition of the WHO head and neck tumor classification. (2017) (10)
Sinonasal malignancies in children: A 10‐year, single‐institutional review (2011) (10)
Quiz case 1. Periosteal osteosarcoma (PO) of the mandible. (2000) (9)
Association between the V 109 G Polymorphism of the p 27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma (2004) (9)
Mdm 2 and Mdm 4 Loss Regulates Distinct p 53 Activities (2008) (9)
N-Terminal Truncated Myb with New Transcriptional Activity Produced Through Use of an Alternative MYB Promoter in Salivary Gland Adenoid Cystic Carcinoma (2019) (9)
Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms (1997) (9)
Squamous carcinoma of oral tongue: prognostic significance of flow-cytometric DNA content. (1992) (9)
Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations (2021) (9)
Craniofacial resection for nonmelanoma skin cancer of the head and neck. Laryngoscope 2005;115:931-937 (2005) (9)
30 : Prediction of Neck Dissection (ND) Requirement Following Definitive Radiotherapy (RT) for Head And Neck Squamous Cell Carcinoma (HNSCC) (2006) (9)
Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression. (1996) (9)
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies (2020) (9)
Constitutive Dicer1 phosphorylation accelerates metabolism and aging in vivo (2018) (9)
Randomized placebo-controlled trial (RCT) of erlotinib for prevention of oral cancer (EPOC). (2014) (8)
Two Perplexing Skin Tumors: Microcystic Adnexal Carcinoma and Keratoacanthoma (1994) (8)
Testicular germ cell tumors. Clinically relevant pathologic findings. (1991) (8)
Epithelial choristomas and teratomas of the tongue. (1993) (8)
Tumor of the Salivary Glands (2016) (8)
Association between a functional polymorphism (‐1195T>C) in the IGFBP5 promoter and head and neck cancer risk (2011) (8)
Serous surface carcinoma of the ovary and peritoneum. A flow cytometric study. (1989) (8)
Concurrent cytogenetic, interphase fluorescence in situ hybridization and DNA flow cytometric analyses of a carcinoma ex-pleomorphic adenoma of parotid gland. (1998) (8)
Genotypic Analysis of Flow‐Sorted and Microdissected Head and Neck Squamous Lesions by Whole‐Genome Amplification (1998) (8)
Genomic and transcriptomic landscape of oral pre-cancers (OPCs) and risk of oral cancer (OC). (2019) (8)
Multispectral and hyperspectral in vivo imaging of the oral cavity for neoplastic tissue detection (2008) (8)
Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma. (2017) (8)
Prognostic implications of DNA index in patients with stage III cutaneous melanoma. (1993) (8)
Pseudosarcomatous Fibromyxoid Tumor of the Prostate: A Case Report with Immunohistochemical, Electron Microscopic, and DNA Flow Cytometric Analysis (1991) (7)
Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy (2018) (7)
Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck (2020) (7)
Synovial sarcoma of the tongue: case report and review of the literature. (1992) (7)
Primary haemangiopericytomas of the parotid gland (1992) (7)
The Clinical Relevance and Assessment of Apoptotic Cell Death (1996) (7)
Optimal Visual Perception and Detection of Oral Cavity Neoplasia Reflectance and Fluorescence (2002) (7)
Retinoid Receptor Subtypes in Sebaceous Cell Carcinoma of the Eyelid (2005) (7)
Immune profiling of oral pre-malignant lesions (OPLs): An Erlotinib Prevention of Oral Cancer (EPOC) study biobank analysis. (2017) (7)
Intracystic papillary carcinoma of the breast [2] (1991) (7)
Wegener's Granulomatosis and Antineutrophil Cytoplasmic Autoantibodies (1993) (7)
Ectopic ACTH Production and Cushing’s Syndrome in a Patient with Parotid Acinic Cell Carcinoma with High-Grade Transformation: Tumor Context and Clinical Implications (2019) (6)
Concurrent epithelioid malignant peripheral nerve sheath tumor and papillary thyroid carcinoma in the treated field of Hodgkin's disease (2008) (6)
Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma (2020) (6)
Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination. (2019) (6)
Mutations in Human Aggressive and Nonaggressive Basal and Squamous Cell Carcinomas 1 (2003) (6)
Prognostic significance of DNA content in stage I adenocarcinoma of the lung. (1998) (6)
Expression of bcr–abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification (2001) (6)
Human Papillomavirus (HPV) and Overall Survival (OS) After Progression of Oropharyngeal Squamous Cell Carcinoma (OPSCC) (2014) (6)
Extraskeletal osteosarcoma of the pleura (2003) (6)
Translocation t(6;14) as the Sole Chromosomal Abnormality in Adenoid Cystic Carcinoma of the Base of Tongue (2007) (6)
Establishment and genomic characterization of primary salivary duct carcinoma cell line. (2017) (6)
Randomized trial of a short course of erlotinib 150 to 300 mg daily prior to surgery for squamous cell carcinomas of the head and neck (SCCHN) in current, former, and never smokers: Objective responses and clinical outcomes. (2011) (6)
Congenital hemangiopericytoma. An ultrastructural, immunocytochemical, and flow cytometric study. (1993) (6)
PI3‐kinase pathway biomarkers in oral cancer and tumor immune cells (2018) (5)
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience (2021) (5)
Tumors of the salivary glands (1978) (5)
Differential expression of Bax and Bcl-2 in the assessment of cellular dynamics in fine-needle samples of primary breast carcinomas. (2000) (5)
Novel t(1;3)(q21,p21) translocation in a basal cell adenocarcinoma of the parotid gland: potential association with tumorigenesis. (2016) (5)
Diagnostic molecular pathology comes of age. (1999) (5)
Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma (2019) (5)
Solitary fibrous tumor. (1993) (5)
Deoxyribonucleic acid flow cytometry on primary adenocarcinoma of the bladder: an analysis of 36 cases. (1989) (5)
Sinonasal carcinoma with neuroendocrine differentiation: patterns of failure according to histologic phenotype (2003) (5)
Incompletely treated malignancies of the major salivary gland: Toward evidence‐based care (2018) (5)
Notch1 mutations to define a subgroup of adenoid cystic carcinoma (ACC): Tumor stage, propensity to bone and liver metastasis, risk of relapse, and overall survival. (2015) (5)
Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration (2018) (5)
Simultaneous renal and transitional cell carcinomas in same kidney with subsequent lymph node metastasis: DNA flow cytometric study. (1991) (5)
Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content. (1996) (5)
Collagenous Myofibroblastic Tumor of the Mandible: Case Report of a Unique Locally Aggressive Neoplasm (2010) (5)
Cellular and Molecular Pathology of Head and Neck Tumors (2011) (5)
Melanoma in a carcinoma ex pleomorphic adenoma of the parotid gland: a case report and putative histogenesis. (2011) (5)
Genetic Variants in DNA Double-Strand Break Repair Genes and Risk of Salivary Gland Carcinoma: A Case-Control Study (2015) (5)
Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association. (2017) (5)
The KRAS-variant and cetuximab response in RTOG 0522. (2014) (5)
Solid tumor DNA ploidy analysis. (1998) (5)
Proteomic profiling of HPV-positive head and neck cancer to identify new candidates for targeted therapy. (2014) (5)
t(3;8) as the sole chromosomal abnormality in a myoepithelial carcinoma ex pleomorphic adenoma: A putative progression event (2013) (4)
Regional DNA content heterogeneity in colonic adenocarcinoma: Prognostic significance in patients with liver metastases (1992) (4)
A Novel Target for Oral Cancer Chemoprevention? Notch Quite, Yet… (2015) (4)
Prognostic biomarkers in patients with human immunodeficiency virus‐positive disease with head and neck squamous cell carcinoma (2017) (4)
Correlation of Src activation with epithelial-mesenchymal transformation and aggressive features of head and neck squamous carcinoma (2007) (4)
Susceptibility and Prevention Δ Np 63 Overexpression , Alone and in Combination with Other Biomarkers , Predicts the Development of Oral Cancer in Patients with Leukoplakia (2009) (4)
Differential gain-of-function activity of three p53 hotspot mutants in vivo. (2022) (4)
Role of COX-2 in tumor progression and survival of head and neck squamous cell carcinoma (4)
Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma (2021) (4)
Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. (2018) (3)
Unsupervised Analysis Uncovers Changes in Histopathologic Diagnosis in Supervised Genomic Studies (2006) (3)
Molecular and Cellular Pathobiology Multiple Stress Signals Activate Mutant p 53 In Vivo (2011) (3)
Gefitinib for advanced cutaneous squamous cell carcinoma of head and neck: Phase II trial. (2016) (3)
Long-term update of NRG/RTOG 0522: a randomized phase III trial of concurrent radiation and cisplatin with or without cetuximab in locoregionally advanced head and neck cancer. (2020) (3)
Early detection and diagnosis of oral premalignant squamous mucosal lesions (2016) (3)
Simultaneous DNA/RNA analysis of solid and hematoreticular malignancies. (1998) (3)
Wide-field and high-resolution optical imaging for early detection of oral neoplasia (2010) (3)
Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life (2021) (3)
Gene therapy strategies for lung cancer (1997) (3)
Profiling of cytokines and angiogenic factors (C/AF) in head and neck (HN) cancer correlates circulating biomarkers with clinical outcomes following induction chemotherapy (2008) (3)
Immunologic profiling of adenoid cystic carcinoma (acc) (2015) (3)
Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics. (1999) (3)
Clinical relevance of the flow cytometric analysis in cancer (1992) (3)
Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified (2021) (3)
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer (2022) (2)
DNA methyltransferase-3B (DNMT3B) in oral cancer (OC) development. (2011) (2)
Pathologic remission of invasive thymoma after induction chemotherapy (1992) (2)
A phase II trial of ZD 1869 for advanced cutaneous squamous cell carcinoma of the head and neck (2007) (2)
Brain metastasis initial presentation of breast cancer: DNA flow cytometric comparison of two sites (1990) (2)
DNA FISH Diagnostic Assay on Cytological Samples of Thyroid Follicular Neoplasms † (2020) (2)
Erratum: Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690) (2019) (2)
Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer (2019) (2)
ADENO p53 GENE TRANSFER IN A PHASE I/II TRIAL OF PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS CARCINOMA (1996) (2)
Mapping and mutational analysis of the human TAF2G gene encoding a p53 cofactor. (1999) (2)
Induction chemotherapy followed by surgical resection for young patients with squamous sell carcinoma of the oral tongue (SCC/T) (2005) (2)
The 3rd salivary gland tumor workshop meeting report (2013) (2)
Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models (2021) (2)
Advances in clinical investigations of salivary gland tumorigenesis. (1999) (2)
Rheumatoid arthritis mimicking metastatic squamous cell carcinoma (2011) (2)
Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. (2020) (2)
Meeting Report—The NIDCR 2nd Salivary Gland Tumor Meeting, November 2008 (2009) (2)
Prad-1 gene amplification in head and neck squamous cell carcinoma (1993) (1)
Abstract 166: CpG island methylation profiling in human salivary gland adenoid cystic carcinoma (2010) (1)
Editorial: How clinically significant is minimal extrathyroidal extension in papillary thyroid cancer? (2016) (1)
Gene replacement for lung cancer (1997) (1)
Evolutionary Action Score of TP 53 Coding Variants ( EAp 53 ) is Predictive of Platinum Response in Head and Neck Cancer Patients (2015) (1)
Multiple unrelated translocations in a metastatic epimyoepithelial carcinoma of the parotid gland. (1998) (1)
Association of activating NOTCH1 mutations in adenoid cystic carcinoma with shorter progression-free survival to systemic therapy. (2017) (1)
Abstract 2357: Novel transgenic animal model of salivary gland tumors (2012) (1)
Tenosynovial Giant Cell Tumors and Other Lesions Traditionally Considered to Be Reactive: Further Evidence for Neoplastic Etiology (1995) (1)
Abstract A14: The p53R172H gain-of-function mutation promotes resistance to oral cancer immunoprevention (2020) (1)
HPV and oropharyngeal cancer mystery: a glimmer of hope! (2016) (1)
A 60-year-old woman with an asymptomatic left lacrimal gland mass found incidentally. (2017) (1)
Pathology and Differential Diagnosis of Anterior Skull Base Tumours. (2020) (1)
Molecular characterization of the PI3/Akt pathway in head and neck squamous cell cancer (HNSCC). (2004) (1)
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck (2021) (1)
Erratum to "Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma" [Hum Pathol 40 (2009) 827-833] (DOI:10.1016/j.humpath.2008.11.003) (2009) (1)
A far‐red fluorescent contrast agent to image epidermal growth factor receptor expression (2004) (1)
TRYHARD, a randomized phase II trial (RTOG Foundation 3501) of concurrent accelerated radiation plus cisplatin (cis) with or without lapatinib (Lap) for stage III- IV Non-HPV head and neck carcinoma (HNC). (2021) (1)
Determining the magnitude of clinical target volumes (CTV) margins based on pathological examination of microscopic extracapsular extension of metastatic neck nodes (2004) (1)
New DNA methylation markers associated with oral cancer (OC) development (dvlpt). (2012) (1)
Role of histopathologic and phenotypic assessment in the development and validation of optical diagnostic devices for head and neck mucosal lesions (2009) (1)
Abstract 5506: NOTCH1 activation in head and neck squamous cell carcinoma leads to growth inhibition, changes in gene expression associated with early differentiation, and acquisition of stem cell-like properties (2018) (1)
Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study (2022) (1)
Near real time confocal imaging of dysplasia in the oral cavity (2002) (1)
Mitochondrial DNA mutations in cancer diagnosis (2003) (0)
Successful biochemoprevention in a patient with multiple aerodigestive malignancies (2007) (0)
Fresh tissue harvest and histopathologic processing of uveal melanoma specimens: Implications for basic research and patient care (2005) (0)
Molecular Alterations in Salivary Gland Tumors (1998) (0)
2129 Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: Outcomes and patterns of failure (1997) (0)
Definitive radiotherapy in basaloid squamous cell carcinoma of the head and neck; need for more aggressive modalities? (2006) (0)
Clinicopathologic Implications of RNA Content (2007) (0)
An A ttenuated A denovirus, O NYX-015, A s M outhwash T herapy for P remalignant O ral D ysplasia (2006) (0)
Surgical Management of Adenoid Cystic Carcinoma of the Lacrimal Gland (2004) (0)
Serologic response to HPV and the risk of head and neck cancer (2008) (0)
Abstract 1611: MYB and the MYB-NFIB fusion induce adenoid cystic carcinoma (2020) (0)
Human Papillomavirus Type 16 Infection and Squamous Cell Carcinoma of the Head and Neck in Never-Smokers : A Matched Pair Analysis 1 (2003) (0)
Diagnostic molecular pathology technology: Concepts, principals, and applications - Introduction (2002) (0)
P2.90. A phase II trial of ZD 1839 (Gefitinib) for advanced cutaneous squamous cell carcinoma of head and neck (2009) (0)
Improvement of clinical response and biomarkers by Camellia sinensis (green tea) extract in patients with high-risk oral premalignant lesions (2010) (0)
Erratum: Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma (Clinical Cancer Research(2006)12(653–61)Doi:10.1158/1078-0432.CCR-05-1725) (2019) (0)
624 Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 nonsmall cell lung cancer (NSCLC) (1997) (0)
Abstract LB-111: Comprehensive proteomic analysis of salivary gland cancer subtypes (2015) (0)
Targeting human EGFR 2 (HER2) in salivary gland carcinoma. (2023) (0)
Abstract 333: Molecular and histologic characterization a patient-derived heterotransplant mouse model of head and neck squamous carcinoma. (2013) (0)
Ocular Non-pigmented Ciliary Adenomatous Neoplasm:Report of a Rare Case and Review of the Clinicopathologic Classification (2014) (0)
588 Exome Sequencing of Adenoid Cystic Carcinoma (2012) (0)
Opinion Article Title: Emerging Roles for Multimodal Optical Imaging in Early Cancer Detection: A Global Challenge Running Title: Multimodal Optical Imaging for Global Cancer Detection (2010) (0)
Advances in Brief High Frequency Loss of Heterozygosity in von Hippel-Lindau ( VHL )-associated and Sporadic Pancreatic Islet Cell Tumors : Evidence for a Stepwise Mechanism for Malignant Conversion in VHL Tumorigenesis 1 (2002) (0)
Integrative proteomic and transcriptomic analysis define adenoid cystic carcinoma subgroups with distinct therapeutic targets (2020) (0)
P123 Proteomic Screening of Saliva in Head and Neck Squamous Carcinoma: A Potential Diagnostic and Screening Application (2006) (0)
One-Stage Model of Experimental Myocardial Infarction in Rats (2011) (0)
Management-Based Pathology Assessment of Salivary Gland Carcinomas (2019) (0)
Fibrous dysplasia - A case of spontaneous involution (1994) (0)
Editor's Note: Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma (2019) (0)
Adult rhabdomyosarcoma: Outcome and prognostic factors (2001) (0)
The KRAS-variant is a Biomarker of Cetuximab Response and Altered Immunity in Head and Neck Cancer: NRG Oncology/RTOG 0522 (2016) (0)
Akt/mammalian target of rapamycin counteract the antitumor activities of cixutumumab an anti-insulin-like growth factor I receptor monoclonal antibody (2011) (0)
Abstract 2361: Establishing a patient-derived heterotransplant mouse model of head and neck squamous carcinoma (HNSCC) (2012) (0)
Oncogenes and Tumor Suppressors Therapeutic Ef fi cacy of p 53 Restoration in Mdm 2-Overexpressing Tumors (2015) (0)
Salivary gland cancer: assessing elusive behavior (2012) (0)
Abstract 1845: Mutant p53 promotes progression and metastasis of mouse oral tumors induced by 4NQO, associated with specific immune infiltrates (2017) (0)
Expression of Bax and Bcl-2 in human rhabdomyosarcoma: Correlation with survival in 64 patients (2005) (0)
MiRNA and mRNA Expression Profiling in Head and Neck Squamous Cell Carcinoma Reveals Aberrantly Expressed miRNA That May Have Prognostic Potential (2009) (0)
Comorbidity and survival in locally advanced laryngeal cancer. (2016) (0)
Oropharynx, Nasopharynx, and Waldeyer Ring (2019) (0)
Long-term Outcomes Following Multidisciplinary Management of T3 Larynx Cancer (2015) (0)
Loss of p53 drives neuron reprogramming in head and neck cancer (2020) (0)
NIMG-62. AMPHETAMINE-ASSOCIATED CNS VASCULITIS MASQUERADING AS TUMOUR (2020) (0)
Corrigendum to “Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non small cell lung cancer (NSCLC)” [Lung Cancer 18 (S1) (1997) 160] (2013) (0)
Interphase cytogenetics of prostatic carcinoma in fine needle aspirate smears of radical prostatectomy specimens: A practical screening tool? (1994) (0)
Retraction Note to: The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells (2021) (0)
Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
Poster 29 Chromosomal Abnormalities in Pleomorphic Adenoma (1995) (0)
Mediastinal lymphoblastic lymphoma with non-lymphoblastic histologic features. (1994) (0)
In Vivo fiber confocal microscopy for detection of oral cavity neoplasia (2006) (0)
Abstract LB-186: MET receptor tyrosine kinase is a potential novel target for prevention of oral cancer. (2013) (0)
A Functional Six-Nucletide Insertion/Deletion Polymorphism in the CASP8 Promoter Region Protects Against Cutaneous Melanoma and Squamous Cell Carcinoma of Head and Neck (2007) (0)
Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-IReceptorAntibody ( A 12 ) in an Orthotopic Nude MouseModel of AnaplasticThyroid Carcinoma (2006) (0)
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases (2018) (0)
Commentary (2009) (0)
Association between human papillomavirus (HPV) status with serum cytokine and angiogenic factor (CAF) profile after induction chemotherapy in head and neck squamous cell carcinoma (HNSCC). (2009) (0)
Surgery Followed by Cornea-Sparing Treatment Approach with Proton Therapy Reduces Orbital Exenteration for Cancer Patients with Periorbital Malignancies (2019) (0)
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma. (2023) (0)
Mucoepidermoid Carcinoma of the Thyroid (2005) (0)
Abstract 5578: SOCS2 (suppressor of cytokine signaling protein 2) is a prognostic indicator of progression-free survival in head and neck squamous cell carcinoma (HNSCC) patients. (2013) (0)
In Memoriam (2009) (0)
z-erbB2 Amplification in Node-negative Human Breast Cancer 1 (2006) (0)
Treatment patterns and systemic therapy outcomes for patients with salivary duct carcinoma and adenocarcinoma NOS. (2021) (0)
Abstract 3441: Proteomic profiling identifies PTK2/FAK as a targetable marker of radioresistance in head and neck cancer (2015) (0)
Analysis of v Integrin Expression in Human Conjunctiva, Eyelid, and Head and Neck Squamous Cell Carcinoma (2008) (0)
An Orthotopic MurineModel of Sinonasal Malignancy (2008) (0)
Advances in Brief In Vivo Molecular Therapy with p 53 Adenovirus for Microscopic Residual Head and Neck Squamous Carcinoma 1 (2006) (0)
Head and Neck Adenoid Cystic Carcinoma: Focus on Outcomes of Intensity Modulated Proton Therapy (2019) (0)
Imprinting in Solid Tumors: Cause or Consequence? (1997) (0)
Pathology of HNSCC (2018) (0)
Dr. John G. Batsakis: 1929-2013 (2013) (0)
Abstract NG07: Cancer takes a nerve: Loss of p53 drives neuron reprogramming in head and neck cancer (2021) (0)
Mario A. Luna, M.D. The University of Texas M.D. Anderson Cancer Center (January 21, 1935 to November 9, 2008) (2009) (0)
Clinical and Pathologic Determinants of Regional Metastases (2016) (0)
A Gene Expression Signature Predicts Recurrence-free Survival and Overall Survival for High-risk Surgical-pathologic Head and Neck Squamous Cell Carcinomas following Post-operative Radiotherapy (2010) (0)
DNA flow cytometric analysis in the assessment of soft-tissue neoplasms (1993) (0)
Abstract PR-10: Randomized placebo controlled trial of pioglitazone for oral premalignant lesions: A cross-consortium collaborative study in progress (2010) (0)
NFkB Helps Regulate the Progression of Adenoid Cystic Carcinoma of the Head and Neck (2005) (0)
Spatial PD‐L1, immune‐cell microenvironment, and genomic copy‐number alteration patterns and drivers of invasive‐disease transition in prospective oral precancer cohort (2023) (0)
Commentary (2002) (0)
Thyroid and Parathyroid Tumors (2020) (0)
Abstract 1511: Differential expression analysis and biomarker identification in five salivary gland carcinoma types (2018) (0)
An Attenuated Adenovirus , ONYX-015 , As Mouthwash Therapy for Premal ignant (2003) (0)
Genetic Alterations andTheir Relationship in the Phosphatidylinositol 3-Kinase / Akt Pathway inThyroid Cancer (2007) (0)
Loss of Fhit expression in head and neck squamous cell carcinoma and its utility in individualized therapy. (2004) (0)
Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC (2023) (0)
Mutant p 53 and Cdkn 2 a deletion induce metastatic SCCs (2016) (0)
RATIO OF MATRIX METALLOPROTEASES (MMP) TO E-CADHERIN (ECAD) EXPRESSION IS AN INDEPENDENT PREDICTOR OF METASTASIS IN RENAL CELL CARCINOMA (RCC) (1999) (0)
Loss of alpha-v integrin and p53 Cooperate to Induce Skin Squamous Cell Carcinomas (2011) (0)
Abstract #4307: Multiple contrast agents for the optical detection of oral neoplasia (2009) (0)
Chapter-014 Pathology (2017) (0)
Erratum: BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells (Cancer Research (November 15, 2004) 64, 1 (8262-8270)) (2004) (0)
Head & neck optical diagnostics (2009) (0)
Local and systemic strategies for gene replacement for cancer (1998) (0)
Enriched expression of PD-L1 and other immune targets after epithelial-mesenchymal transition (EMT) in squamous head and neck and lung cancers. (2015) (0)
Clinicopathologic Features and Long-Term Outcomes of 293 Phyllodes Tumors of the Breast (2008) (0)
Overexpression of the p53 inhibitor MDM4 in Head and Neck Squamous Carcinomas (2009) (0)
Oral Premalignant Lesions Chromosome Polysomy and Histological Characteristics in Updated (2001) (0)
Tumors of the Salivary Gland (2020) (0)
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
Outcomes of Head and Neck Adenoid Cystic Carcinoma Treated Definitively With Surgery and Postoperative Intensity Modulated Radiation Therapy (2015) (0)
P060 Significance of Insulinlike Growth Factor Receptor I in the Development of Anaplastic Thyroid Cancer (2006) (0)
Neoplasms of Thyroid: Follicular thyroid carcinoma (2017) (0)
Sinonasal and Skull Base Tumors (2020) (0)
Gene expression profiling of oral preneoplastic lesions (OPL) from a prospective prevention trial. (2010) (0)
John G. Batsakis, MD (1929-2013): a historical perspective on his contributions to pathology. (2014) (0)
2156 Prognostic significance of DNA content in clinical Stage I adenocarcinoma of the lung (1997) (0)
O58. Quality assurance measures in patients treated for early oral tongue cancer (2009) (0)
Pathology of Head and Neck Tumors (2020) (0)
Abstract 1235: Induction of a p21 mediated senescence program by p53 impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer (2011) (0)
ANovelTargetforOralCancerChemoprevention? Notch Quite, Yet ... (2015) (0)
Mutations in Nonmelanoma Skin Cancer of the Head and Neck : Molecular Evidence for Field Cancerization 1 (2006) (0)
Flow cytometric analysis of ovarian adult type granulosa cell tumors (1999) (0)
Recurrent parathyroid carcinoma and the need for molecular profiling to aid in prognostication and therapeutics. (2015) (0)
THE PROGNOSTIC SIGNIFICANCE OF ANGIOGENIC FACTOR EXPRESSION IN RENAL CELL CARCINOMA (RCC) (1999) (0)
Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. (2022) (0)
Molecular diagnostics of head and neck cancer (2013) (0)
Abstract P3-03-03: A mouse model of sporadic breast tumor with a conditionalP53mutation (2016) (0)
Pathology of Tumor and Tumor-like Lesions of the Skull Base (2008) (0)
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers (2021) (0)
3 – Head and Neck (1962) (0)
DNA flow cytometry in the assessment of solid neoplasms. (1992) (0)
Abstract 1958: Signals activating mutant p53 in vivo (2010) (0)
Erratum: Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma (2012) (0)
Prognostic value of biomarkers in tissue microarrays (TMAs) of squamous cell carcinomas of the oral tongue (SCCOT). (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Adel. K. El‐naggar?

Adel. K. El‐naggar is affiliated with the following schools:

MD Anderson Cancer Center

Adel. K. El‐naggar's Academic­Influence.com Rankings

Why Is Adel. K. El‐naggar Influential?

Adel. K. El‐naggar's Published Works

Published Works

What Schools Are Affiliated With Adel. K. El‐naggar?

Adel. K. El‐naggar's AcademicInfluence.com Rankings